LDS/Medical Tests/PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Beta) Gene Mutation Analysis

PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Beta) Gene Mutation Analysis

The PPP2R2B gene located on the long (q) arm of chromosome 5 at position 32 encodes the brain-specific regulatory subunit B of protein phosphatase 2. Protein phosphatase 2A (PP2A), a heterotrimeric serine/threonine phosphatase, has been implicated in a variety of regulatory processes, including cell growth and division, muscle contraction, and gene transcription. PP2A is composed of a 36-kD catalytic subunit, a highly homologous 65-kD structural subunit, and any of several different regulatory subunits that control its specificity, including PPP2R2B. Mutations of the PPP2R2B gene are associated with autosomal dominant neurodegenerative disorder known as spinocerebellar ataxia 12 (SCA12).

SCA12 is a very rare subtype of type I autosomal dominant cerebellar ataxia (ADCA). It is characterized by the presence of action tremor associated with relatively mild cerebellar ataxia. Due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord affected individual show progressive incoordination of gait and often-poor coordination of hands, speech, and eye movements. The pathogenesis of SCA12 is related to a toxic effect at the RNA level, as SCA12 is associated with an expansion of a CAG repeat in the 5’ region of the gene PPP2R2B. The repeat size ranges from 9 to 28 triplets in normal alleles and 55 to 78 triplets in the mutant allele of affected individuals. This CAG repeat expansion may cause dysregulated expression of PPP2R2B gene. SCA12 is the only SCA in which the mutation may increase gene expression; in this case, because the gene product is involved in regulation of PP2A, abnormal phosphatase activity may be critical to SCA12 pathogenesis.

  • Diagnosis of spinocerebellar ataxia type 12 (SCA12) in patients with cerebellar ataxia
  • For the diagnosis of SCA12 in symptomatic family members of known SCA12 patients
  • For the prenatal diagnosis of spinocerebellar ataxia type 12

Positive

  • 55-78 CAG trinucleotide repeat in the PPP2R2B gene indicates spinocerebellar ataxia type 12 (SCA12) in patients with cerebellar ataxia

Negative 

  • 9-28 CAG trinucleotide repeat in the PPP2R2B gene shows no indication of spinocerebellar ataxia type 12 (SCA12) in patients with cerebellar ataxia

< 28 CAG trinucleotide repeats in the PPP2R2B gene

Repeat Expansion Detection by PCR, Next generation sequencing for sequence analysis, Deletion/duplication analysis by exon array, MLPA, and NGS.

Whole blood.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Prenatal diagnosis (PND), preimplantation genetic diagnosis (PGD), complete panel of SCA tests.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login